<DOC>
	<DOCNO>NCT01877590</DOCNO>
	<brief_summary>Cardiovascular complication account high mortality type 2 diabetic patient , mainly due coronary artery disease ( CAD ) . Most attention treat CAD type 2 diabetes understandably direct toward treat coronary artery condition . However treatable culprit patient . Left ventricular hypertrophy ( LVH ) widespread type 2 diabetic patient CAD , even absence hypertension . It strong predictor cardiovascular event all-cause mortality . Regression LVH associate improved prognosis , independent change blood pressure ( BP ) . Therefore , cardiovascular event mortality type 2 diabetes CAD might reduce investigator find novel therapy regress LVH . Alpha-lipoic acid reduces oxidative stress regress LVH . Alpha-lipoic acid improve endothelial function diabetic condition . Hence , main aim study ass whether alpha-lipoic acid could regress LVM type 2 diabetic patient CAD .</brief_summary>
	<brief_title>Alpha-lipoic Acid Reduces Left Ventricular Mass Normotensive Type 2 Diabetic Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Type 2 diabetes CAD Left ventricular hypertrophy HbA1c 7.0 % blood pressure &lt; 130/80 mmHg Patients exclude currently alphalipoic acid one year , previous adverse reaction alphalipoic acid . hey also exclude renal liver dysfunction , heart failure , malignancy , unable give inform consent . Patients contraindication cardiac magnetic resonance ( CMR ) ( pacemaker , claustrophobia ) also exclude , pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>